← Leaderboards
Yao Liang Tang
Keck Graduate Inst Of Applied Life Scis
$6,672,201
Attributed
$10,080,768
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,080,768 · 4
By mechanism
R01$10,080,768 · 4
Top collaborators
- Muhammad Ashraf9 shared
- Neal L Weintraub9 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingStem CellsCellsSignal TransductionRepairedPreconditioningMyocardial IschemiaCardiacOverexpressionResponseHeartHypoxiaNatural RegenerationMyocardial InfarctionHomingRegenerativeIn VivoAngiogenesisIschemiaBaseCell SurvivalHomologous GenePlayGene Expression
Grant awards (23)
Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair$509,007
R01 · FY2025 · HL · contact PI
Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair$498,828
R01 · FY2024 · HL · contact PI
Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair$509,007
R01 · FY2023 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$499,954
R01 · FY2021 · AR · contact PI
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2020 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$515,417
R01 · FY2020 · AR · contact PI
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2019 · HL · contact PI
Hypoxia and cardiac stem cell homing$380,000
R01 · FY2019 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$528,617
R01 · FY2018 · AR · contact PI
Hypoxia and cardiac stem cell homing$380,000
R01 · FY2018 · HL · contact PI
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2017 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$541,817
R01 · FY2017 · AR · contact PI
Hypoxia and cardiac stem cell homing$380,000
R01 · FY2017 · HL · contact PI
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$634,413
R01 · FY2016 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$528,394
R01 · FY2016 · AR · contact PI
Hypoxia and cardiac stem cell homing$380,000
R01 · FY2016 · HL · contact PI
Hypoxia and cardiac stem cell homing$268,013
R01 · FY2012 · HL · contact PI
Hypoxia and cardiac stem cell homing$120,562
R01 · FY2012 · HL · contact PI
Hypoxia and cardiac stem cell homing$392,500
R01 · FY2011 · HL · contact PI
Hypoxia and cardiac stem cell homing$392,500
R01 · FY2010 · HL · contact PI
Hypoxia and cardiac stem cell homing$316,324
R01 · FY2009 · HL · contact PI
Hypoxia and cardiac stem cell homing$62,426
R01 · FY2009 · HL · contact PI
Hypoxia and cardiac stem cell homing$378,750
R01 · FY2008 · HL · contact PI